Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease.
Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E.
Matsubara E, et al. Among authors: abe k.
J Neurochem. 2003 Jun;85(5):1101-8. doi: 10.1046/j.1471-4159.2003.01654.x.
J Neurochem. 2003.
PMID: 12753069
Free article.